Comparison of Clinical Outcomes of Short-Course vs Long-Course Antibiotic Treatment in Children With Pyelonephritis

Warda  Zahid; Yusra  Kafait; Anum  Zahra; Tooba  Kafait; Hamza Hussain  Mirza; Muhammad  Saleem

doi:10.54112/bcsrj.v6i6.1743

Authors

Warda Zahid Department of Surgery, Shahida Khaliq Hospital, Islamabad, Pakistan
Yusra Kafait Divisional Headquarters Teaching Hospital Mirpur AJK, Pakistan
Anum Zahra Elaj Hospital Islamabad, Pakistan
Tooba Kafait Divisional Headquarters Teaching Hospital Mirpur AJK, Pakistan
Hamza Hussain Mirza Department of Surgery, Shahida Khaliq Hospital, Islamabad, Pakistan
Muhammad Saleem Department of Urology, Ayub Teaching Hospital, Abbottabad, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v6i6.1743

Keywords:

Antibiotics, Bacteria, Pediatrics, Pyelonephritis

Abstract

To evaluate the comparative effectiveness of short-course vs long-course antibiotic treatment for clinical outcomes of children with pyelonephritis. Methodology: A retrospective observational study was conducted in the Pediatrics Department of PIMS Hospital, Islamabad, between May 2024 and May 2025. A total of 200 children aged from 6 months to 18 years presenting in the outpatient department with urine culture showing the presence of Escherichia coli, Klebsiella species, or Proteus mirabilis were selected for the study. Children were divided into two treatment groups by physicians; Group A included 100 patients who were administered the short-course antibiotic treatment for 6-9 days, and Group B included 100 patients treated for 10 or more days. The primary endpoint was treatment failure, shown by the occurrence of one or more composite outcomes in 1 month following treatment. Results: The odds ratio of achieving the composite outcomes at follow-up between both groups was 1.19 (95% CI: 0.81-2.02). There was no significant difference between outcomes concerning age between both groups however between the age groups, children aged 4-13 years had a significantly higher frequency of treatment failure (14.7%) as compared to other age groups (9 vs 8.2%) irrespective of treatment (OR: 1.68, 95% CI: 1.12-2.81, p<0.01). 40% patients in Group A and 65% in Group B had a recurrence with an increasingly resistant organism at follow-up (OR: 0.40, 95% CI: 0.11-1.48). Conclusion: The effect of short-course and long-course antibiotic treatment is similar in children with pyelonephritis. However, short-course therapy is superior for reducing the risks of drug-resistant infection recurrence.

Downloads

Download data is not yet available.

References

Ciccarese F, Brandi N, Corcioni B, Golfieri R, Gaudiano C. Complicated pyelonephritis associated with chronic renal stone disease. La radiologia medica. 2021;126:505-516.

Zimmerman DE, Tomas M, Miller D, Tomcsanyi L, Signorella C, Montepara CA, et al. Cephalosporins for the treatment of uncomplicated pyelonephritis: A systematic review. Journal of the American Pharmacists Association. 2023;63(5):1461-1471.

Erba L, Furlan L, Monti A, Marsala E, Cernuschi G, Solbiati M, et al. Short vs long-course antibiotic therapy in pyelonephritis: a comparison of systematic reviews and guidelines for the SIMI Choosing Wisely campaign. Internal and Emergency Medicine. 2021;16:313-323.

Russo E, Viazzi F. Duration of antibiotic therapy in pyelonephritis: when shorter is better. Internal and Emergency Medicine. 2021;16(2):259-261.

Schneider-Smith E, Bacher B, Morgan-Gillard X, Yaeger L, Durkin MJ, Marschall J, editors. 1214. Short versus long antibiotic treatment duration for febrile urinary tract infection and acute pyelonephritis: A systematic review and meta-analysis. Open Forum Infectious Diseases; 2023: Oxford University Press US.

Zahavi I, Kunwar D, Olchowski J, Dallasheh H, Paul M. Short versus long antibiotic treatment for pyelonephritis and complicated urinary tract infections: a living systematic review and meta-analysis of randomized controlled trials. Clinical Microbiology and Infection. 2025.

Baba K, Ito K, Oki R, Furuya Y, Magari T, Ogura H, et al. Impacts of clinical backgrounds and intervention strategies on duration of intravenous antibiotic treatments in patients diagnosed with calculous pyelonephritis: A single-center retrospective study. Journal of Infection and Chemotherapy. 2025;31(2):102559.

Lessard D-A, Huard-Girard T, Tremblay A, Turcotte J-F. Transition to oral antibiotic therapy for pyelonephritis in children under 60 days of age: An observational retrospective cohort study. Paediatrics & Child Health. 2021;26(1):27-31.

Zahavi I, Kunwar D, Olchowski J, Dallasheh H, Paul M. Short vs. long antibiotic treatment for pyelonephritis and complicated urinary tract infections: a living systematic review and meta-analysis of randomized controlled trials. Clinical Microbiology and Infection. 2025.

Meena J, Kumar J. Adjuvant corticosteroids for prevention of kidney scarring in children with acute pyelonephritis: a systematic review and meta-analysis. Archives of Disease in Childhood. 2021;106(11):1081-1086.

Moreira MVB, de Freitas LR, Fonseca LM, Moreira MJB, Balieiro CCA, Marques IR, et al. Shorter versus longer-course of antibiotic therapy for urinary tract infections in the pediatric population: an updated meta-analysis. European Journal of Pediatrics. 2024;183(5):2037-2047.

Hikmat S, Lawrence J, Gwee A. Short intravenous antibiotic courses for urinary infections in young infants: a systematic review. Pediatrics. 2022;149(2):e2021052466.

Lin K, Zahlanie Y, Ortwine JK, Wei W, Mang NS, Prokesch BC. A retrospective review of oral cephalosporins versus fluoroquinolones for the treatment of pyelonephritis. Plos one. 2022;17(9):e0274194.

Dunne MW, Aronin SI, Das AF, Akinapelli K, Breen J, Zelasky MT, et al. Sulopenem for the treatment of complicated urinary tract infections including pyelonephritis: a phase 3, randomized trial. Clinical Infectious Diseases. 2023;76(1):78-88.